Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The antiviral drug Paxlovid may not offer much protection against COVID-related hospitalizations or deaths for ...

Novo Nordisk plans to offer its Wegovy weight loss drug at a reduced cost of $499 per month for cash-paying customers in the ...

President Donald Trump said he’s “just getting started” in an address to Congress. Ukraine’s president put forward plans for a partial ceasefire with Russia. Thirty guards at a juvenile hall were ...

A new study suggests Paxlovid may not reduce the risk of covid-19 hospitalizations and all-cause deaths in vaccinated adults ...

Shrewd investors know that bear markets open up great opportunities to pick up shares of excellent companies from the discount bin. However, even in a bull market, like the one we're currently ...

About 5% of U.S. adults are estimated to be living with long COVID-19, and one of them is UC San Francisco epidemiologist and ...

Pfizer's Q4/24 results showed significant improvements, with total revenue up 21.9% YoY and adjusted diluted EPS increasing ...

During the pandemic,COVID-19 killed more than 7 million people worldwide, including 1.2 million in the U.S. and more than ...

With growing cases of measles in Texas and Lubbock reporting the states first death, local health officials hosted a news ...

Adults aged more than 70 who received more prescriptions for nirmatrelvir-ritonavir did not show decreased rates of ...

A new analysis of health data from Ontario, Canada, suggests that nirmatrelvir-ritonavir (Paxlovid) may provide limited benefit for vaccinated older adults with COVID-19, despite its previously proven ...